Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Aug;44(8):1797-1816.
doi: 10.1007/s10096-025-05148-y. Epub 2025 May 5.

The virulence toolkit of Staphylococcus aureus: a comprehensive review of toxin diversity, molecular mechanisms, and clinical implications

Affiliations
Review

The virulence toolkit of Staphylococcus aureus: a comprehensive review of toxin diversity, molecular mechanisms, and clinical implications

Stefano Di Bella et al. Eur J Clin Microbiol Infect Dis. 2025 Aug.

Abstract

Purpose: This review examines the pathogenic mechanisms of Staphylococcus aureus, emphasizing its toxin-driven virulence factors, including pore-forming toxins, exfoliative toxins, and superantigens.

Methods: This paper was conducted using the available literature (PubMed/MEDLINE/Google Scholar and books written by experts in pharmacology and infectious diseases).

Results: Toxins are crucial in promoting tissue invasion, immune system evasion, and the development of systemic diseases. Notably, the qualitative and quantitative expression of these toxins influences the clinical presentation and severity of S. aureus infections. The paper explores toxins' role in S. aureus pathogenesis and clinical manifestations as well as current and emerging therapeutic strategies aimed at targeting these toxins, including antibiotics, monoclonal antibodies, and anti-inflammatory treatments. Additionally, it highlights the potential of novel inhibitors and vaccines to neutralize specific toxins and prevent toxin-mediated diseases.

Conclusion: By combining antimicrobial therapies with approaches that neutralize toxins and modulate the immune response, clinicians can improve outcomes in patients affected by S. aureus infections.

Keywords: Staphylococcus aureus; Anti-inflammatory treatments; Antibiotic therapy; Monoclonal antibodies; Toxins.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval: Not applicable. Consent to participate: Not applicable. Consent to publish: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
General principles of pore-forming toxins (PFT) mechanism. Pore-forming toxins interact with cell membranes through specific binding to a membrane receptor or direct interaction with membrane components. Depending on the toxin class, the binding mechanism differs. Upon binding, the toxins oligomerize to form pores in the membrane, leading to dysregulated ion fluxes that ultimately results in cell death
Fig. 2
Fig. 2
General principles of Exfoliative Toxins (ET) mechanism. ET specifically cleaves desmoglein-1, a critical component of cell junctions, leading to cell detachment and the exfoliation of epithelial tissue
Fig. 3
Fig. 3
General principles of Superantigens mechanism. Superantigens can directly bind MHC class II molecules to T-cell receptors, triggering a constitutive and non-specific activation of T cells independent of specific antigens. This leads to a chain reaction resulting in the so-called cytokine storm and the massive activation of T cells, which ultimately undergo cell death
Fig. 4
Fig. 4
Relationship between SCCmec element and toxin production in HA-MRSA vs. CA-MRSA
Fig. 5
Fig. 5
Main cell type targets for the different toxins are shown

References

    1. Krismer B, Weidenmaier C, Zipperer A, Peschel A The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota. Nat Rev Microbiol 2017 12;15:675–687. 10.1038/nrmicro.2017.104 - PubMed
    1. Bai AD, Lo CKL, Komorowski AS, Suresh M, Guo K, Garg A et al (2022) Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis. Clin Microbiol Infect 28:1076–1084. 10.1016/j.cmi.2022.03.015 - PubMed
    1. Laupland KB, Lyytikäinen O, Søgaard M, Kennedy KJ, Knudsen JD, Ostergaard C et al (2013) The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect 19:465–471. 10.1111/j.1469-0691.2012.03903.x - PubMed
    1. Sause WE, Buckley PT, Strohl WR, Lynch AS, Torres VJ (2016) Antibody-Based biologics and their promise to combat Staphylococcus aureus infections. Trends Pharmacol Sci 37:231–241. 10.1016/j.tips.2015.11.008 - PMC - PubMed
    1. Tam K, Torres VJ (2019) Staphylococcus aureus secreted toxins and extracellular enzymes. Microbiol Spectr 7. 10.1128/microbiolspec.GPP3-0039-2018 - PMC - PubMed

MeSH terms

LinkOut - more resources